JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Mohamed, K.O | |
| dc.contributor.author | Elsahar, A.E | |
| dc.contributor.author | Faggal, S.I | |
| dc.contributor.author | Kamal, A.M | |
| dc.contributor.author | Shabaan, M.A. | |
| dc.date.accessioned | 2020-02-14T14:16:15Z | |
| dc.date.available | 2020-02-14T14:16:15Z | |
| dc.date.issued | 2020 | |
| dc.identifier.citation | Pereira-Leite, C., Nunes, C., Jamal, S.K., Cuccovia, I.M., Reis, S. Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety (2017) Medicinal Research Reviews, 37 (4), pp. 802-859. Cited 28 times. http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-1128 doi: 10.1002/med.21424 View at Publisher 2 Whelton, A., Watson, A.J. (1998) Clinical Nephrotoxins, pp. 203-216. Springer, Dordrecht, The Netherlands 3 Meade, E.A., Smith, W.L., DeWitt, D.L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti- inflammatory drugs (1993) Journal of Biological Chemistry, 268 (9), pp. 6610-6614. Cited 1151 times. View at Publisher 4 Bresalier, R.S., Sandler, R.S., Quan, H., Bolognese, J.A., Oxenius, B., Horgan, K., Lines, C., (...), Baron, J.A. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial (2005) New England Journal of Medicine, 352 (11), pp. 1092-1102. Cited 2137 times. doi: 10.1056/NEJMoa050493 View at Publisher 5 Dogné, J.-M., Supuran, C.T., Pratico, D. Adverse cardiovascular effects of the coxibs (2005) Journal of Medicinal Chemistry, 48 (7), pp. 2251-2257. Cited 288 times. doi: 10.1021/jm0402059 View at Publisher 6 Harirforoosh, S., Asghar, W., Jamali, F. Adverse effects of nonsteroidal antiinflammatory drugs: An update of gastrointestinal, cardiovascular and renal complications (2013) Journal of Pharmacy and Pharmaceutical Sciences, 16 (5), pp. 821-847. Cited 207 times. http://ejournals.library.ualberta.ca/index.php/JPPS/article/view/21249/16078 View at Publisher 7 De Gaetano, G., Donati, M.B., Cerletti, C. Prevention of thrombosis and vascular inflammation: Benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors (2003) Trends in Pharmacological Sciences, 24 (5), pp. 245-252. Cited 106 times. www.elsevier.com/locate/tips doi: 10.1016/S0165-6147(03)00077-4 View at Publisher 8 Martel-Pelletier, J., Lajeunesse, D., Reboul, P., Pelletier, J.-P. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs (Open Access) (2003) Annals of the Rheumatic Diseases, 62 (6), pp. 501-509. Cited 259 times. doi: 10.1136/ard.62.6.501 View at Publisher 9 Yang, K., Ma, W., Liang, H., Ouyang, Q., Tang, C., Lai, L. Dynamic simulations on the arachidonic acid metabolic network (Open Access) (2007) PLoS Computational Biology, 3 (3), pp. 0523-0530. Cited 82 times. http://compbiol.plosjournals.org/archive/1553-7358/3/3/pdf/10.1371_journal.pcbi.0030055-L.pdf doi: 10.1371/journal.pcbi.0030055 View at Publisher 10 Laufer, S., Gay, S., Brune, K. (2003) Inflammation and Rheumatic Diseases: The Molecular Basis of Novel Therapies. Cited 4 times. Georg Thieme Verlag, Stuttgart, NY 11 Celotti, F., Laufer, S. Anti-inflammatory drugs: New multitarget compounds to face an old problem. The dual inhibition concept (2001) Pharmacological Research, 43 (5), pp. 429-436. Cited 133 times. http://www.elsevier.com/inca/publications/store/6/2/2/9/3/1/index.htt doi: 10.1006/phrs.2000.0784 View at Publisher 12 Blackham, A., Griffiths, R.J., Hallam, C., Mann, J., Mitchell, P.D., Norris, A.A., Simpson, W.T. FPL 62064, a topically active 5-lipoxygenase/cyclooxygenase inhibitor (1990) Agents and Actions, 30 (3-4), pp. 432-442. Cited 13 times. doi: 10.1007/BF01966309 View at Publisher 13 Argentieri, D.C., Ritchie, D.M., Ferro, M.P., Kirchner, T., Wachter, M.P., Anderson, D.W., Rosenthale, M.E., (...), Capetola, R.J. Tepoxalin: A dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile (1994) Journal of Pharmacology and Experimental Therapeutics, 271 (3), pp. 1399-1408. Cited 102 times. 14 Wallace, J.L., McCafferty, D.-M., Carter, L., McKnight, W., Argentieri, D. Tissue-selective inhibition of prostaglandin synthesis in rat by tepoxalin: Anti-inflammatory without gastropathy? (1993) Gastroenterology, 105 (6), pp. 1630-1636. Cited 74 times. doi: 10.1016/0016-5085(93)91057-O View at Publisher 15 Anderson, D.W., Argentien, D.C., Ritchie, D.M., Katz, L.B., Shriver, D.A., Rosenthale, M.E., Capetola, R.J. (1990) FASEB J., 4, p. A1122. Cited 16 times. 16 Araico, A., Terencio, M.C., Alcaraz, M.J., Domínguez, J.N., León, C., Ferrándiz, M.L. Phenylsulphonyl urenyl chalcone derivatives as dual inhibitors of cyclo-oxygenase-2 and 5-lipoxygenase (2006) Life Sciences, 78 (25), pp. 2911-2918. Cited 25 times. doi: 10.1016/j.lfs.2005.11.017 View at Publisher 17 Araico, A., Terencio, M.C., Alcaraz, M.J., Domínguez, J.N., León, C., Ferrándiz, M.L. Evaluation of the anti-inflammatory and analgesic activity of Me-UCH9, a dual cyclooxygenase-2/5-lipoxygenase inhibitor (2007) Life Sciences, 80 (23), pp. 2108-2117. Cited 25 times. doi: 10.1016/j.lfs.2007.03.017 View at Publisher 18 Shaaban, M.A., Soliman, L.N., Roshdy, S.M.A., Mohamed, K.O.A. (2009) Bull. Fac. Pharm., 47, p. 35. Cited 5 times. 19 Gupta, P., Gupta, J.K., Halve, A.K. (2015) Int. J. Pharm. Sci., 6, p. 2291. Cited 24 times. 20 Arbačiauskiene, E., Tolaityte, S.K., Mitrulevičiene, A., Bieliauskas, A., Martynaitis, V., Bechmann, M., Roller, A., (...), Holzer, W. On the Tautomerism of N-Substituted Pyrazolones: 1,2-Dihydro-3H-pyrazol-3-ones versus 1H-Pyrazol-3-ols (Open Access) (2018) Molecules, 23 (1), art. no. 129. Cited 7 times. http://www.mdpi.com/1420-3049/23/1/129/pdf doi: 10.3390/molecules23010129 View at Publisher 21 Mariappan, G., Saha, B.P., Sutharson, L., Haldar, A. (2010) 49B, 1671 22 Mandour, A.H., El-Sawy, E.R., Ebaid, M.S., Hassan, S.M. Synthesis and potential biological activity of some novel 3-[(N-substituted indol-3-yl)methyleneamino]-6-amino-4-aryl-pyrano(2,3-c)pyrazole-5-carbonitriles and 3,6-diamino-4-(N-substituted indol-3-yl)pyrano(2,3-c)pyrazole-5- carbonitriles (Open Access) (2012) Acta Pharmaceutica, 62 (1), pp. 15-30. Cited 22 times. doi: 10.2478/v10007-012-0007-0 View at Publisher 23 Srivalli, T., Satish, K., Suthakaran, R. (2011) Int. J. Innov. Pharm. Res., 2, p. 172. Cited 8 times. 24 Sahu, S.K., Banerjee, M., Samantray, A., Behera, C., Azam, M.A. (2008) Trop. J. Pharm. Res., 7, p. 961. Cited 87 times. 25 Charlier, C., Michaux, C. Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs (2003) European Journal of Medicinal Chemistry, 38 (7-8), pp. 645-659. Cited 313 times. http://www.journals.elsevier.com/european-journal-of-medicinal-chemistry/ doi: 10.1016/S0223-5234(03)00115-6 View at Publisher 26 Abdelgawad, M.A., Labib, M.B., Ali, W.A.M., Kamel, G., Azouz, A.A., EL-Nahass, E.L.-S. Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies (2018) Bioorganic Chemistry, 78, pp. 103-114. Cited 16 times. http://www.elsevier.com/inca/publications/store/6/2/2/7/9/4/index.htt doi: 10.1016/j.bioorg.2018.03.011 View at Publisher 27 Chen, H., Li, Q., Yao, X., Fan, B., Yuan, S., Panaye, A., Doucet, J.P. CoMFA/CoMSIA/HQSAR and Docking study of the binding mode of selective cyclooxygenase (COX-2) inhibitors (2004) QSAR and Combinatorial Science, 23 (1), pp. 36-55. Cited 21 times. doi: 10.1002/qsar.200330844 View at Publisher 28 Llorens, O., Perez, J.J., Palomer, A., Mauleon, D. Structural basis of the dynamic mechanism of ligand binding to cyclooxygenase (1999) Bioorganic and Medicinal Chemistry Letters, 9 (19), pp. 2779-2784. Cited 49 times. doi: 10.1016/S0960-894X(99)00481-3 View at Publisher 29 Kurumbail, R.G., Stevens, A.M., Gierse, J.K., McDonald, J.J., Stegeman, R.A., Pak, J.Y., Gildehaus, D., (...), Stallings, W.C. Structural basis for selective inhibition of cyciooxygenase-2 by anti-inflammatory agents (1996) Nature, 384 (6610), pp. 644-648. Cited 1374 times. http://www.nature.com/nature/index.html doi: 10.1038/384644a0 View at Publisher 30 Garavito, R.M., Dewitt, D.L. The cyclooxygenase isoforms: Structural insights into the conversion of arachidonic acid to prostaglandins (1999) Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1441 (2-3), pp. 278-287. Cited 132 times. doi: 10.1016/S1388-1981(99)00147-X View at Publisher 31 Moussa, G., Alaaeddine, R., Alaeddine, L.M., Nassra, R., Belal, A.S.F., Ismail, A., El-Yazbi, A.F., (...), Hazzaa, A. Novel click modifiable thioquinazolinones as anti-inflammatory agents: Design, synthesis, biological evaluation and docking study (2018) European Journal of Medicinal Chemistry, 144, pp. 635-650. Cited 15 times. http://www.journals.elsevier.com/european-journal-of-medicinal-chemistry/ doi: 10.1016/j.ejmech.2017.12.065 View at Publisher 32 Rowlinson, S.W., Kiefer, J.R., Prusakiewicz, J.J., Pawlitz, J.L., Kozak, K.R., Kalgutkar, A.S., Stallings, W.C., (...), Marnett, L.J. A Novel Mechanism of Cyclooxygenase-2 Inhibition Involving Interactions with Ser-530 and Tyr-385 (Open Access) (2003) Journal of Biological Chemistry, 278 (46), pp. 45763-45769. Cited 202 times. doi: 10.1074/jbc.M305481200 View at Publisher 33 Soliva, R., Almansa, C., Kalko, S.G., Luque, F.J., Orozco, M. Theoretical studies on the inhibition mechanism of cyclooxygenase-2. Is there a unique recognition site? (2003) Journal of Medicinal Chemistry, 46 (8), pp. 1372-1382. Cited 55 times. doi: 10.1021/jm0209376 View at Publisher 34 Shimokawa, T., Kulmacz, R.J., DeWitt, D.L., Smith, W.L. Tyrosine 385 of prostaglandin endoperoxide synthase is required for cyclooxygenase catalysis (1990) Journal of Biological Chemistry, 265 (33), pp. 20073-20076. Cited 188 times. View at Publisher 35 Ganorkar, S.B., Vander Heyden, Y., Shirkhedkar, A.A., Lokwani, D.K., Dhumal, D.M., Bobade, P.S. (2019) J. Pharm. Biomed. Anal. 36 El-Nagar, M.K.S., Abdu-Allah, H.H.M., Salem, O.I.A., Kafafy, A.-H.N., Farghaly, H.S.M. Novel N-substituted 5-aminosalicylamides as dual inhibitors of cyclooxygenase and 5-lipoxygenase enzymes: Synthesis, biological evaluation and docking study (2018) Bioorganic Chemistry, 78, pp. 80-93. Cited 4 times. http://www.elsevier.com/inca/publications/store/6/2/2/7/9/4/index.htt doi: 10.1016/j.bioorg.2018.02.023 View at Publisher 37 Abdel-Aziz, A.A.-M., Abou-Zeid, L.A., Eltahir, K.E.H., Ayyad, R.R., El-Sayed, M.A.-A., El-Azab, A.S. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3 H)-quinazolinones (2016) European Journal of Medicinal Chemistry, 121, pp. 410-421. Cited 34 times. http://www.journals.elsevier.com/european-journal-of-medicinal-chemistry/ doi: 10.1016/j.ejmech.2016.05.066 View at Publisher 38 Abdelrahman, M.H., Youssif, B.G.M., abdelgawad, M.A., Abdelazeem, A.H., Ibrahim, H.M., Moustafa, A.E.G.A., Treamblu, L., (...), Bukhari, S.N.A. Synthesis, biological evaluation, docking study and ulcerogenicity profiling of some novel quinoline-2-carboxamides as dual COXs/LOX inhibitors endowed with anti-inflammatory activity (2017) European Journal of Medicinal Chemistry, 127, pp. 972-985. Cited 16 times. http://www.journals.elsevier.com/european-journal-of-medicinal-chemistry/ doi: 10.1016/j.ejmech.2016.11.006 View at Publisher 39 Roschek, B., Fink, R.C., Li, D., McMichael, M., Tower, C.M., Smith, R.D., Alberte, R.S. Pro-inflammatory enzymes, cyclooxygenase 1, cyclooxygenase 2, and 5- lipooxygenase, inhibited by stabilized rice bran extracts (2009) Journal of Medicinal Food, 12 (3), pp. 615-623. Cited 57 times. doi: 10.1089/jmf.2008.0133 View at Publisher 40 Koksal, M., Ozkan-Dagliyan, I., Ozyazici, T., Kadioglu, B., Sipahi, H., Bozkurt, A., Bilge, S.S. Some Novel Mannich Bases of 5-(3,4-Dichlorophenyl)-1,3,4-oxadiazole-2(3H)-one and Their Anti-Inflammatory Activity (2017) Archiv der Pharmazie, 350 (9), art. no. 1700153. www.interscience.wiley.com doi: 10.1002/ardp.201700153 View at Publisher 41 Ahmed, E.M., Kassab, A.E., El-Malah, A.A., Hassan, M.S.A. Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents (2019) European Journal of Medicinal Chemistry, 171, pp. 25-37. Cited 3 times. http://www.journals.elsevier.com/european-journal-of-medicinal-chemistry/ doi: 10.1016/j.ejmech.2019.03.036 View at Publisher 42 Winter, C.A., Risley, E.A., Nuss, G.W. Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Antiinflammatory Drugs (1962) Proceedings of the Society for Experimental Biology and Medicine, 111 (3), pp. 544-547. Cited 5645 times. doi: 10.3181/00379727-111-27849 View at Publisher 43 Mohamed, L.W., Shaaban, M.A., Zaher, A.F., Alhamaky, S.M., Elsahar, A.M. Synthesis of new pyrazoles and pyrozolo [3,4-b] pyridines as anti-inflammatory agents by inhibition of COX-2 enzyme (2019) Bioorganic Chemistry, 83, pp. 47-54. Cited 6 times. http://www.elsevier.com/inca/publications/store/6/2/2/7/9/4/index.htt doi: 10.1016/j.bioorg.2018.10.014 View at Publisher 44 Ibrahim, T.H., Loksha, Y.M., Elshihawy, H.A., Khodeer, D.M., Said, M.M. Synthesis of Some Novel 2,6-Disubstituted Pyridazin-3(2H)-one Derivatives as Analgesic, Anti-Inflammatory, and Non-Ulcerogenic Agents (2017) Archiv der Pharmazie, 350 (9), art. no. 1700093. Cited 7 times. www.interscience.wiley.com doi: 10.1002/ardp.201700093 View at Publisher 45 Manivannan, E., Chaturvedi, S.C. Analogue-based design, synthesis and molecular docking analysis of 2,3-diaryl quinazolinones as non-ulcerogenic anti-inflammatory agents (2011) Bioorganic and Medicinal Chemistry, 19 (15), pp. 4520-4528. Cited 36 times. doi: 10.1016/j.bmc.2011.06.019 View at Publisher 46 Clementi, G., Caruso, A., Cutuli, V.M.C., De Bernardis, E., Prato, A., Mangano, N.G., Amico-Roxas, M. Effects of centrally or peripherally injected adrenomedullin on reserpine-induced gastric lesions (1998) European Journal of Pharmacology, 360 (1), pp. 51-54. Cited 20 times. doi: 10.1016/S0014-2999(98)00688-8 View at Publisher 47 Abd El Razik, H.A., Badr, M.H., Atta, A.H., Mouneir, S.M., Abu-Serie, M.M. Benzodioxole–Pyrazole Hybrids as Anti-Inflammatory and Analgesic Agents with COX-1,2/5-LOX Inhibition and Antioxidant Potential (2017) Archiv der Pharmazie, 350 (5), art. no. 1700026. Cited 19 times. www.interscience.wiley.com doi: 10.1002/ardp.201700026 | en_US |
| dc.identifier.issn | 3656233 | |
| dc.identifier.other | https://doi.org/10.1002/ardp.201900308 | |
| dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/32031284 | |
| dc.description | scopus | en_US |
| dc.description.abstract | New pyrazolone derivatives structurally related to celecoxib and FPL 62064 were synthesized and biologically evaluated for their inhibitory activity against cyclooxygenases (COXs) and 5-lipoxygenase (5-LOX) and their selectivity indices were calculated. The results showed that compounds 3f, 3h, 3l, and 3p have an excellent COX-2 selectivity index. Moreover, they showed potent 5-LOX inhibitory activity relative to celecoxib and zileuton, as positive controls. These promising candidates were further investigated for anti-inflammatory activity using the carrageenan-induced rat paw edema method and ulcerogenic liability. The results showed no ulceration, which implies their gastric safety profile. Moreover, these compounds were evaluated for prostaglandin (PGE2) production in rat serum. Molecular docking in the COX-2 and 5-LOX active sites was performed to rationalize their anti-inflammatory activities. Strong binding interactions and effective docking scores were identified. The results indicated that these derivatives are good leads for dual-acting COX-2/5-LOX inhibitors to be used as potent and safe anti-inflammatory agents. © 2020 Deutsche Pharmazeutische Gesellschaft | en_US |
| dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=19956&tip=sid&clean=0 | |
| dc.language.iso | en | en_US |
| dc.publisher | Wiley-VCH Verlag | en_US |
| dc.relation.ispartofseries | Archiv der Pharmazie;2020, Article number e1900308 | |
| dc.subject | pyrazolone | en_US |
| dc.subject | PGE2 | en_US |
| dc.subject | COX-2 inhibitors | en_US |
| dc.subject | anti-inflammatory | en_US |
| dc.subject | 5-LOX | en_US |
| dc.title | Synthesis and biological evaluation of pyrazolone analogues as potential anti-inflammatory agents targeting cyclooxygenases and 5-lipoxygenase | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | https://doi.org/10.1002/ardp.201900308 | |
| dc.Affiliation | October University for modern sciences and Arts (MSA) |
